Researchers have identified a key weakness in acute myeloid ... leukemia (AML). The research is published in The EMBO Journal ...

Leukemia occurs when the bone marrow begins to produce abnormal cells. This happens when the bone marrow cells' genetic material ... to an increased risk of acute myeloid leukemia (AML).

A patient's prognosis is a function of both patient- and leukemia-related ... with cytogenetically normal AML will now have one or more discernable recurrent genetic mutations.

It will be important to identify unique patterns of clustered genetic changes that may ... produce clinically significant results. AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia ...

has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with acute myeloid leukemia ...

Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent ... for adults with acute myeloid leukemia (AML) or myelodysplastic ...

has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with acute myeloid leukemia ...

However, the relationship between LR pairs and the prognosis of AML, as well as their impact on treatment ... For our analysis of genomic variations, we sourced the Simple Nucleotide Variation (SNV) ...

The ontogenesis of myeloid malignancies is based on complex genetic alterations and biological mechanisms ... especially myelodysplastic syndromes and acute myeloid leukemia (AML). Therapeutic agents ...

The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of ...